Efficacy and Safety of Postbiotic (Metabiotic) Contained Inactivated Lactobacillus reuteri (Limosilactobacillus Reuteri) DSM 17648 as Adjuvant Therapy in the Eradication of Helicobacter pylori in Adults with Functional Dyspepsia: A Randomized Double-
How to cite: Ivashkin, V.; Maev, I.; Poluektova, E.; Sinitsa, A.; Avalueva, E.; Mnatsakanyan, M.; Simanenkov, V.; Karpeeva, J.; Kopylova, D.; Kuprina, I.; Kucheryavyy, Y.; Lapina, T.; Solovyeva, O.; Soom, M.; Cheremushkina, N.; Maevskaya, E.; Holz, C.; Maslennikov, R. Efficacy and Safety of Postbiotic (Metabiotic) Contained Inactivated Lactobacillus reuteri (Limosilactobacillus Reuteri) DSM 17648 as Adjuvant Therapy in the Eradication of Helicobacter pylori in Adults with Functional Dyspepsia: A Randomized Double-. Preprints 2023, 2023120836. https://doi.org/10.20944/preprints202312.0836.v1 Ivashkin, V.; Maev, I.; Poluektova, E.; Sinitsa, A.; Avalueva, E.; Mnatsakanyan, M.; Simanenkov, V.; Karpeeva, J.; Kopylova, D.; Kuprina, I.; Kucheryavyy, Y.; Lapina, T.; Solovyeva, O.; Soom, M.; Cheremushkina, N.; Maevskaya, E.; Holz, C.; Maslennikov, R. Efficacy and Safety of Postbiotic (Metabiotic) Contained Inactivated Lactobacillus reuteri (Limosilactobacillus Reuteri) DSM 17648 as Adjuvant Therapy in the Eradication of Helicobacter pylori in Adults with Functional Dyspepsia: A Randomized Double-. Preprints 2023, 2023120836. https://doi.org/10.20944/preprints202312.0836.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)